Immunic Inc
IMUX·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$7.91
Today
-7.9%
YTD
+56.5%
About
Immunic, Inc. is a clinical-stage biopharmaceutical company engaged in the development of oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Founded in 2003, the company is headquartered in New York and operates internationally. Immunic is listed on NASDAQ GS under the IMUX ticker. Find out more about IMUX stock by adding it to your eToro watchlist.
Price chart
Closing price history for IMUX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-1.66
P/S (TTM)0.00
P/B (TTM)0.85
Market cap$108.61M
Cap tierMicro-cap
Industry avg P/E-7.37
Profitability
Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-138.17%
ROA-101.15%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$4.81
Free cash flow$-88.05M
Total debt$567,000.00
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.38
Employees92
Next earnings12 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.